The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 6.12 — safe zoneOK
- Earnings-manipulation signal · Beneish M -1.50 — flag raised, worth a closer lookWatch
- Earnings quality 39/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as Organogenesis Holdings Inc. reports it. History and quarterly detail are in the app.
- Product$563.0M
- Grant$1.1M
Leadership changes
From Organogenesis Holdings Inc.'s own filings, the day they're filed.
- Patrick McGuire · Chief Accounting Officer · appointmenteff. 2026-02-18
- Garrett Lustig · Directors · appointmenteff. 2024-11-12
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-16
- 8-K · Company announcement2026-05-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Organogenesis Holdings Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when Organogenesis Holdings Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.